UMeWorld Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UMeWorld Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	0	0.01	0	0	0	0	0	0	0	0
Cost of revenue	0	0.02	0.07	0	0	0.02	0	0	0	0.01
Gross profit	0	-0.02	-0.07	-0	0	-0.02	-0	-0	-0	-0.01
General and administrative	0.96	0.9	0.39	0.12	0.13	0.09	0.09	0.3	0.22	0.22
Operating expenses	0.96	0.9	0.39	0.12	0.13	0.09	0.09	0.3	0.22	0.25
Operating income	-0.96	-0.92	-0.46	-0.12	-0.13	-0.1	-0.09	-0.31	-0.22	-0.26
Interest expense	0.22	0.39	0.67	0	0
Interest income							0	0	0
Other non-operating income	-0.22	-0.39	-0.39	0	-0.01	-0	0	0	0	0
Pre-tax income	-1.18	-1.31	-0.85	-0.12	-0.15	-0.11	-0.08	-0.31	-0.22	-0.26
Income tax	0	0	0	0	0	0	0	0	0	0
Income from continuing operations					-0.15	-0.11	-0.08	-0.31	-0.22
Net income to minority interests	0.02	0.02	0	0	0
Net income	-1.18	-1.31	-0.85	-0.12	-0.15	-0.11	-0.15	-0.31	-0.22	-0.26
EBITDA	-0.96	-0.91	-0.45	-0.12	-0.13	-0.1	-0.09	-0.31	-0.22
EPS, basic			-0.01	0.00	0.00	0.00
EPS, diluted	-0.01	-0.02	-0.01	0.00	0.00	0.00
Shares, basic (weighted)	89.2	89.4	89.4	105	107	109
Shares, diluted (weighted)	89.2	89.4	89.4	105	107	109	110	110	111	113

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents	0.05	0.01	0.01	0	0.02	0.01	0	0.06	0.12	0.15
Receivables	0.01	0						0	0	0
Inventory						0	0.01	0	0	0.01
Other current assets	0.03	0.02	0	0	0	0.03	0	0	0	0
Total current assets	0.08	0.03	0.02	0.01	0.02	0.04	0.03	0.06	0.12	0.17
Property, plant and equipment	0.01	0	0	0	0	0.02	0	0
Total assets	0.09	0.03	0.02	0.01	0.02	0.06	0.03	0.06	0.12	0.17
Accounts payable	0.19	0.26	0.02	0.02	0.02	0.02	0.02	0	0	0
Accrued liabilities	0.14	0.3	0.19	0.22	0.23	0.21	0.15	0.17	0.21	0.04
Deferred revenue	0.38
Total current liabilities	1.15	1.71	0.27	0.38	0.36	0.26	0.38	0.43	0.49	0.49
Total liabilities	2.95	4.07	0.27	0.38	0.36	0.26	0.38	0.43	0.49	0.49
Paid-in capital	25.2	25.4	30.3	30.3	30.4	30.7	30.7	31.1	31.3	31.6
Retained earnings	-28.4	-29.8	-30.6	-30.7	-30.9	-31	-31.1	-31.4	-31.7	-31.9
Other comprehensive income	0.15	0.09	0.09	0.09	0.12	0.12	0.12	0	0	0
Shareholders' equity	-2.85	-4.03	-0.25	-0.37	-0.35	-0.21	-0.35	-0.38	-0.37	-0.32
Minority interests	0.22	0.23	0
Total equity	-3.07	-4.27	-0.25	-0.37	-0.35	-0.21	-0.35	-0.38	-0.37	-0.32
Total liabilities and equity	0.09	0.03	0.02	0.01	0.02	0.06	0.03	0.06	0.12	0.17
Shares outstanding	89.3	89.5	105	105	107	110	110	111	112	115

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	-1.18	-1.31	-0.85	-0.12	-0.15	-0.11	-0.15	-0.31	-0.22	-0.26
Depreciation and amortization	0.01	0.01	0	0	0	0	0	0	0
Stock-based compensation	0.66
Change in receivables	-0	-0.01	0.01	-0	-0.01	0	-0	0	-0	-0
Change in inventory					0	0	-0.01	0.01	-0	-0.04
Change in payables	0.07	0.07	0.03	0	-0	0	-0	-0.02	-0	0
Cash from operations	-0.64	-0.51	-0.24	-0.01	-0.07	-0.12	-0.11	-0.07	-0.03	-0.11
Capital expenditures				0	0	-0.02	0	0
Cash from investing				0	0	-0.02	0	0
Stock issued	0	0.05	0.15	0	0.14	0.25	0	0.21	0.2	0.3
Cash from financing	0.35	0.48	0.25	0	0.07	0.12	0.11	0.12	0.09	0.15
Exchange rate effect	-0.01	-0.01	-0.01	-0	0.02	0.01	0	0	0	0
Net change in cash	-0.3	-0.04	-0	-0.01	0.02	-0.01	-0.01	0.05	0.06	0.03
Free cash flow				-0.01	-0.07	-0.14	-0.11	-0.07
Interest paid	0	0	0	0	0	0	0	0	0	0
Income taxes paid	0	0	0	0	0	0	0	0	0	0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.15 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	5.9%	Gross profit / revenue.
Operating margin	-51.8%	Operating income / revenue.
Pre-tax margin	-51.8%	Pre-tax income / revenue.
Net margin	-51.8%	Net income / revenue.
Operating cash flow margin	-39.9%	Cash from operations / revenue.
Return on assets (ROA)	-35.6%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	136.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	188.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	253.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	39.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	83.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	58.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.83x	Current assets / current liabilities.
Quick ratio	0.34x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.05x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	120.3%	Total liabilities / total assets.
Working capital	-$306.3K	Current assets - current liabilities.
Tangible book value	-$306.3K	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.69x	Revenue / average total assets.
Inventory turnover	1.10x	Cost of revenue / average inventory.
Days inventory	332 days	365 x average inventory / cost of revenue.
Receivables turnover	1.96x	Revenue / average receivables.
Days sales outstanding	186 days	365 x average receivables / revenue.
Days payables	513 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	5 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.01	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.00	Cash from operations / diluted weighted shares.
Book value per share	-$0.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.00	Tangible book value / shares outstanding.
Cash per share	$0.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$133.5M	Share price x shares outstanding.
Enterprise value	$133.4M	Market cap + total debt - cash - short-term investments.
P/S	128x	Market cap / revenue.
EV/Sales	128x	Enterprise value / revenue.
Earnings yield	-0.4%	Net income / market cap (the inverse of P/E).

What was UMeWorld Inc.'s revenue in fiscal 2025?

UMeWorld Inc. reported revenue of $2.2K for fiscal 2025, 136.1% higher than the year before.

Was UMeWorld Inc. profitable in fiscal 2025?

No. It reported a net loss of $258.2K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UMeWorld Inc.